Outcomes Among Patients with EGFR-Mutant Metastatic NSCLC with and without Brain Metastases

被引：3
|
作者：
Nadler, E. [1 ]
Pavilack, M. [2 ]
Espirito, J. [3 ]
Baidoo, B. [3 ]
Fernandes, A. [2 ]
机构：
[1] Baylor Charles A Sammons Canc Ctr, Texas Oncol, Dallas, TX USA
[2] Astrazeneca, Gaithersburg, MD USA
[3] Mckesson Specialty Hlth, The Woodlands, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
NSCLC; brain metastases;
D O I：
10.1016/j.jtho.2018.08.380
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.06
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [1] Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
    Wan-Ling Tan
    Quan Sing Ng
    Cindy Lim
    Eng Huat Tan
    Chee Keong Toh
    Mei-Kim Ang
    Ravindran Kanesvaran
    Amit Jain
    Daniel S. W. Tan
    Darren Wan-Teck Lim
    [J]. BMC Cancer, 18
  • [2] Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment
    Ma, J.
    Li, Y.
    Lai, G. G. Y.
    Tan, E-H.
    Lim, W. D. T.
    Ang, M-K.
    Ng, Q. S.
    Kanesvaran, R.
    Jain, A.
    Rajasekaran, T.
    Fong, K. W.
    Siow, T. R.
    Thiagarajan, A.
    Yap, S. P.
    Chia, S. H. B.
    Ng, W. L.
    Tan, D. S. W.
    Tan, S. H.
    Tan, W. L.
    Chua, K. L. M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S970 - S970
  • [3] Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
    Tan, Wan-Ling
    Ng, Quan Sing
    Lim, Cindy
    Tan, Eng Huat
    Toh, Chee Keong
    Ang, Mei-Kim
    Kanesvaran, Ravindran
    Jain, Amit
    Tan, Daniel S. W.
    Lim, Darren Wan-Teck
    [J]. BMC CANCER, 2018, 18
  • [4] Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
    Wan-Ling Tan
    Quan Sing Ng
    Cindy Lim
    Eng Huat Tan
    Chee Keong Toh
    Mei-Kim Ang
    Ravindran Kanesvaran
    Amit Jain
    Daniel S. W. Tan
    Darren Wan-Teck Lim
    [J]. BMC Cancer, 18
  • [5] Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastases
    Saida, Yu
    Watanabe, Satoshi
    Abe, Tetsuya
    Shoji, Satoshi
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Kondo, Rie
    Koyama, Kenichi
    Miura, Satoru
    Tanaka, Hiroshi
    Okajima, Masaaki
    Terada, Masaki
    Ishide, Takashi
    Tsukada, Hiroki
    Makino, Masato
    Iwashima, Akira
    Sato, Kazuhiro
    Matsumoto, Naoya
    Yoshizawa, Hirohisa
    Kikuchi, Toshiaki
    [J]. THORACIC CANCER, 2019, 10 (11) : 2106 - 2116
  • [6] Optimal treatment sequence for untreated EGFR-mutant NSCLC with brain metastases
    Miyawaki, Eriko
    Kenmotsu, Hirotsugu
    Harada, Hideyuki
    Mitsuya, Koichi
    Mamesaya, Nobuaki
    Kawamura, Takahisa
    Kobayashi, Haruki
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakasu, Yoko
    Takahashi, Toshiaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC
    Imber, Brandon S.
    Sehgal, Ryka
    Saganty, Rachel
    Reiner, Anne S.
    Ilica, A. Turan
    Miao, Emily
    Li, Bob T.
    Riely, Gregory J.
    Yu, Helena A.
    Panageas, Katherine S.
    Young, Robert J.
    Pike, Luke R. G.
    Moss, Nelson S.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (12):
  • [8] Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)
    Tan, Wan-Ling
    Ng, Quan Sing
    Lim, Cindy
    Tan, Eng Huat
    Toh, Chee Keong
    Ang, Mei-Kim
    Kanesvaran, Ravindran
    Jain, Amit
    Tan, Daniel S. W.
    Lim, Darren Wan-Teck
    [J]. BMC CANCER, 2018, 18
  • [9] Characteristics and outcomes of Latino patients with EGFR-mutant NSCLC.
    Mathew, Matthen
    Lagos, Galina G.
    Rao, Nisha
    Asmar, Ramsey Nicholas
    Liu, Xinhua
    Rizvi, Naiyer A.
    Orjuela, Manuela A.
    Shu, Catherine A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Preclinical Activity of AZD9291 in EGFR-Mutant NSCLC Brain Metastases
    Ballard, Peter
    Yang, Pamela
    Cross, Darren
    Yates, James
    Finlay, M. Raymond V.
    Grist, Matthew
    Box, Matthew
    Johnstrom, Peter
    Varnas, Katerina
    Malmquist, Jonas
    Halldin, Christer
    Farde, Lars
    Thress, Kenneth
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S300 - S300
12345